ADAPT Algorithm for Cardiac Event Risk - Evidencio
ADAPT Algorithm for Cardiac Event Risk
A simplified model to indicate the risk of a major adverse coronary event (MACE)

Clinical indication
The Calculator is intended to be used for patients presenting to the Emergency Department with Chest Pain aged 18 years or older.
Pētījumu autori: Martin Than, Louise Cullen, Sally Aldous, William A. Parsonage, Christopher M. Reid, Jaimi Greenslade, Dylan Flaws, Christopher J. Hammett, Daren M. Beam, Michael W. Ardagh, Richard Troughton, Anthony F. T. Brown, Peter George, Christopher M. Florkowski, Jeffrey A. Kline, Frank Peacock, Alan S. Maisel, Swee Han Lim, Arvin Lamanna, A. Mark Richards
Versija: 2.5
  • Publiski
  • Kardioloģija
  • {{ modelType }}
V-2.5-158.24.05.31
(01)08719327522721(8012)v2.5(4326)240531(240)158
Lejupielādēt Lietotāja rokasgrāmata un skatiet Paredzētais lietojums.
Vienības

{{section.title}}

Aprēķiniet rezultātu

Iestatiet vairāk parametru, lai veiktu aprēķinu

30-day risk of MACE is %

{{ resultSubheader }}
{{ $t('download_result_availability') }}
{{ chart.title }}
Rezultātu intervāls {{ additionalResult.min }} uz {{ additionalResult.max }}

Nosacījumu informācija

It should be noted that, while the ADAPT can be used with contemporary cardiac troponin assays, it performs better with high-sensitivity cardiac troponin assays (hs-cTn), especially for the Fairly Low Risk category.

In the derivation study of Than et al. (2012) using contemporary (not high-sensitivity) troponin assays (Abbott ARCHITECT cTnI assay and DxI Access Accu cTnI assay)
Low Risk: 1 out of 392 patients had a Major Adverse Cardiac Event within 30 days (0.26% risk)
Fairly Low Risk: 8 out of 367 patients had a Major Adverse Cardiac Event within 30 days (2.18% risk)
High Risk: 293 out of 1216 patients had a Major Adverse Cardiac Event within 30 days (24.1% risk)

In a Validation study by Cullen et al. (2013) using the ARCHITECT High Sensitive STAT Troponin-I assay
Low Risk: 0 out of 550 patients had a Major Adverse Cardiac Event within 30 days (0% risk)
Fairly Low Risk: 3 out of 479 patients had a Major Adverse Cardiac Event within 30 days (0.63% risk)
High Risk: 400 out of 1515 patients had a Major Adverse Cardiac Event within 30 days (26.4% risk)

A pooled analysis of multiple studies containing 3163 patients with a total of 487 events found a sensitivity of 99.79% and a negative predictive value of 99.86% for the Low Risk category

A pooled analysis of multiple studies exclusively using hs-cTn assays containing 4021 patients with a total of 646 events found a sensitivity of 99.23% and a negative predictive value of 99.68% for the combined categories of Low Risk and Fairly Low Risk.

{{ file.classification }}
PRO
Piezīme
Piezīmes ir redzamas tikai rezultātu lejuplādētajā versijā un Evidencio tās nesaglabā.

Aprēķini vien nedrīkst noteikt pacientu aprūpi, un tie nevar aizstāt profesionālu vērtējumu. Skatīt mūsu pilnu disclaimer.

Pamatalgoritmi Daļa no
logo

Lūdzu, pierakstieties, lai iespējotu Evidencio drukāšanas funkcijas

Lai izmantotu Evidencio drukāšanas funkcijas, Jums ir jābūt autorizētam.
Ja Jums nav Evidencio kopienas konta, Jūs varat izveidot savu bezmaksas personīgo kontu:

https://www.evidencio.com/registration.

Izdrukāti rezultāti - Piemēri {{ new Date().toLocaleString() }}

Evidencio Kopienas konta priekšrocības

With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.

Atruna: Aprēķini vien nekad nedrīkst noteikt pacienta aprūpi, un tie nevar aizstāt profesionālu vērtējumu.
Terms & Conditions | Privacy Policy | Disclaimer | Contact | Refuse cookies |
Evidencio v3.36 © 2015 - 2025 Evidencio. All Rights Reserved